Collin R. Anderson

Statistics

Publications

Citations

221

H-Index

Active since

2003

Affiliations

United States Food and Drug Administration(Current)

National Cancer Institute

Science Applications International Corporation (United States)

National Institutes of Health

Collin R. Anderson is an author at United States Food and Drug Administration specializing in cancer pharmacology, antineoplastic drug therapy, and medicinal chemistry.

Publications per year

2003–2020

Publications

Antineoplastic Agents. 487. Synthesis and Biological Evaluation of the Antineoplastic Agent 3,4-Methylenedioxy-5,4‘-dimethoxy-3‘-amino-Z-stilbene and Derived Amino Acid Amides

George R. Pettit, Collin R. Anderson, Delbert L. Herald et al. · Journal of Medicinal Chemistry · 2003 · 58 citations

Medicine, Medicinal Chemistry, Pharmacology +12

ASPEN Lipid Injectable Emulsion Safety Recommendations, Part 1: Background and Adult Considerations

Jay M. Mirtallo, Phil Ayers, Joseph I. Boullata et al. · Nutrition in Clinical Practice · 2020 · 54 citations · Full text

Pharmacy, Nutrition, Nutritional Sciences +15

Determination of putrescine and cadaverine in seafood (finfish and shellfish) by liquid chromatography using pyrene excimer fluorescence

Heidi S. Marks, Collin R. Anderson · Journal of Chromatography A · 2005 · 40 citations

Life Sciences, Biochemistry, Marine Sciences +6

Analysis of Carbon Monoxide in Commercially Treated Tuna (Thunnus spp.) and Mahi-Mahi (Coryphaena hippurus) by Gas Chromatography/Mass Spectrometry

Collin R. Anderson, Wen‐Hsin Wu · Journal of Agricultural and Food Chemistry · 2005 · 30 citations

Life Sciences, Fisheries, Marine Sciences +13

Antineoplastic Agents. 590. X-ray Crystal Structure of Dolastatin 16 and Syntheses of the Dolamethylleuine and Dolaphenvaline Units

George R. Pettit, Thomas H. Smith, Jun‐Ping Xu et al. · Journal of Natural Products · 2011 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +12

1–5 of 7